共 54 条
[1]
Badros A(2006)Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors J Clin Oncol 24 945-952
[2]
Weikel D(2005)Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors J Clin Oncol 23 8580-8587
[3]
Salama A(2001)Metastatic bone disease: clinical features, pathophysiology and treatment strategies Cancer Treat Rev 27 165-176
[4]
Goloubeva O(2005)Osteonecrosis of the jaw and bisphosphonates N Engl J Med 351 99-102
[5]
Schneider A(2006)Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates Laryngoscope 116 115-120
[6]
Rapoport A(2005)Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 63 682-689
[7]
Bamias A(2007)Zoledronate-induced S phase arrest and apoptosis accompanied by DNA damage and activation of the ATM/Chk1/cdc25 pathway in human osteosarcoma cells Int J Oncol 31 285-291
[8]
Kastritis E(2003)Related pamidronate and zoledronate induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 1115-1117
[9]
Bamia C(2005)Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy Cancer 104 83-93
[10]
Moulopoulos LA(2003)New insights into the molecular mechanisms of action of bisphosphonates Curr Pharm Des 9 2643-2658